Related Experiment Video
Updated: Jul 15, 2026
12:04
The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
Published on: November 1, 2015
[Pathophysiology of systemic lupus erythematosus]
Patrick Blanco1, Jean-Luc Pellegrin, Jean-François Moreau
1Clinique de médecine interne, Hôpital Haut-Lévêque, Pessac, France. patrick.blanco@u-bordeaux2.fr
Presse Medicale (Paris, France : 1983)
|April 24, 2007
Summary
Innate immunity, particularly dendritic cells and toll-like receptors (TLR), drives lupus. Interferon-alpha is a key factor and a potential therapeutic target for this autoimmune disease.
Area of Science:
- Immunology
- Autoimmune Diseases
- Cell Biology
Background:
- Innate immunity plays a crucial role in the development of systemic lupus erythematosus (SLE).
- Dendritic cells and toll-like receptors (TLRs) are key components of the innate immune system implicated in lupus pathophysiology.
- Immune complexes contribute to the activation of innate immune pathways in lupus.
Purpose of the Study:
- To elucidate the role of innate immunity, specifically dendritic cells and TLRs, in lupus pathogenesis.
- To highlight the significance of interferon-alpha as a critical factor in lupus.
- To identify interferon-alpha as a potential therapeutic target for lupus.
Main Methods:
- Analysis of the dendritic cell system in lupus.
- Investigation of toll-like receptor (TLR) activation by immune complexes.
- Assessment of interferon-alpha's role in lupus pathophysiology.
Main Results:
- Dendritic cells are activated in lupus and capture nuclear antigen-containing bodies.
- Toll-like receptor (TLR) activation by immune complexes contributes to lupus.
- Interferon-alpha is identified as a key mediator in the pathophysiology of lupus.
Conclusions:
- Innate immunity, through dendritic cells and TLRs, is fundamentally involved in lupus.
- Interferon-alpha is a critical factor in lupus pathogenesis and a promising target for immune therapy.
- Targeting innate immune pathways, including interferon-alpha, may offer new therapeutic strategies for lupus.
Related Concept Videos
01:29Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
01:24Nephrotic Syndrome I : Introduction
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
01:12Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
01:25Acute Inflammation III: Local and Systemic Effects
Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...